PMC:7441788 / 17258-17674
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T179 | 134-135 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T222 | 42-47 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T223 | 65-70 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T224 | 127-132 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T225 | 232-237 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T127 | 0-19 | Sentence | denotes | Mahévas et al [53]. |
| T128 | 20-238 | Sentence | denotes | Comparative study HCQ group: n = 84; control group: n = 97 HCQ 600 mg/day for 7 days Compared with control group, a reduction of admissions to ICU or death 7 days after hospital admission was not observed in HCQ group. |
| T129 | 239-305 | Sentence | denotes | Relatively larger sample size in HCQ treatment and control groups. |
| T130 | 306-416 | Sentence | denotes | Nonrandomized design; In propensity score model, four possible important prognostic variables were unbalanced. |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 667 | 38-41 | Chemical | denotes | HCQ | MESH:D006886 |
| 668 | 79-82 | Chemical | denotes | HCQ | MESH:D006886 |
| 669 | 228-231 | Chemical | denotes | HCQ | MESH:D006886 |
| 670 | 272-275 | Chemical | denotes | HCQ | MESH:D006886 |
| 710 | 170-175 | Disease | denotes | death | MESH:D003643 |
LitCovid-sample-PD-GO-BP-0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T64 | 170-175 | http://purl.obolibrary.org/obo/GO_0016265 | denotes | death |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 667 | 38-41 | Chemical | denotes | HCQ | MESH:D006886 |
| 668 | 79-82 | Chemical | denotes | HCQ | MESH:D006886 |
| 669 | 228-231 | Chemical | denotes | HCQ | MESH:D006886 |
| 670 | 272-275 | Chemical | denotes | HCQ | MESH:D006886 |
| 710 | 170-175 | Disease | denotes | death | MESH:D003643 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T127 | 0-19 | Sentence | denotes | Mahévas et al [53]. |
| T128 | 20-238 | Sentence | denotes | Comparative study HCQ group: n = 84; control group: n = 97 HCQ 600 mg/day for 7 days Compared with control group, a reduction of admissions to ICU or death 7 days after hospital admission was not observed in HCQ group. |
| T129 | 239-305 | Sentence | denotes | Relatively larger sample size in HCQ treatment and control groups. |
| T130 | 306-416 | Sentence | denotes | Nonrandomized design; In propensity score model, four possible important prognostic variables were unbalanced. |